Search research articles
Contact Us
Filters
Showing results (21-30 of 30) with videos related to
Page
of 3
Sort By:
You have reached the last page of results.
This site can display upto 30 results.
BMJ Open
|
August 5, 2021
Cost-effectiveness of the fixed-dose combination tiotropium/olodaterol versus tiotropium monotherapy or a fixed-dose combination of long-acting β2-agonist/inhaled corticosteroid for COPD in Finland, Sweden and the Netherlands: a model-based study
Martine Hoogendoorn, Isaac Corro Ramos, Stéphane Soulard, et al.
Analytical Biochemistry
|
October 17, 2002
Two-photon excitation fluorometric measurement of homogeneous microparticle immunoassay for C-reactive protein
Matti E Waris, Niko J Meltola, Juhani T Soini, et al.
Expert Review of Pharmacoeconomics & Outcomes Research
|
September 30, 2016
Cost-utility analysis of vortioxetine versus agomelatine, bupropion SR, sertraline and venlafaxine XR after treatment switch in major depressive disorder in Finland
Erkki Soini, Taru Hallinen, Mélanie Brignone, et al.
JHLT Open
|
March 27, 2025
Pulmonary hypertension in Finland 2008-2020: A descriptive real-world cohort study (FINPAH)
Markku Pentikäinen, Piia Simonen, Helena Tuunanen, et al.
Pulmonary Circulation
|
February 5, 2025
Treatment pathways in Finnish patients with pulmonary arterial hypertension (PAH) or chronic thromboembolic pulmonary hypertension (CTEPH)
Markku Pentikäinen, Piia Simonen, Pauliina Leskelä, et al.
Scandinavian Journal of Gastroenterology
|
April 6, 2021
A nationwide real-world study on dynamic ustekinumab dosing and concomitant medication use among Crohn's disease patients in Finland
Taina Sipponen, Clas-Göran Af Björkesten, Taru Hallinen, et al.
Scandinavian Journal of Gastroenterology
|
June 12, 2019
Ustekinumab for Crohn's disease: a nationwide real-life cohort study from Finland (FINUSTE)
Anja Eberl, Taru Hallinen, Clas-Göran Af Björkesten, et al.
European Journal of Gastroenterology & Hepatology
|
February 19, 2025
Ustekinumab for ulcerative colitis: a nationwide real-life observational cohort study
Pauliina Molander, Clas-Göran Af Björkesten, Hans Henricson, et al.
Acta Dermato-Venereologica
|
December 14, 2021
Guselkumab Treatment Outcomes and Persistence in a Nationwide Real-world Cohort of Patients with Plaque Psoriasis
Tarja Mälkönen, Pauliina Nuutinen, Taru Hallinen, et al.
European Journal of Gastroenterology & Hepatology
|
September 2, 2020
Objectively assessed disease activity and drug persistence during ustekinumab treatment in a nationwide real-world Crohn's disease cohort
Clas-Göran Af Björkesten, Tuire Ilus, Taru Hallinen, et al.
Page
of 3
Search research articles
Search
Showing results (21-30 of 30) with videos related to
Sort By:
Page
of 3
You have reached the last page of results.
This site can display upto 30 results.
BMJ Open
|
August 5, 2021
Cost-effectiveness of the fixed-dose combination tiotropium/olodaterol versus tiotropium monotherapy or a fixed-dose combination of long-acting β2-agonist/inhaled corticosteroid for COPD in Finland, Sweden and the Netherlands: a model-based study
Martine Hoogendoorn, Isaac Corro Ramos, Stéphane Soulard, et al.
Analytical Biochemistry
|
October 17, 2002
Two-photon excitation fluorometric measurement of homogeneous microparticle immunoassay for C-reactive protein
Matti E Waris, Niko J Meltola, Juhani T Soini, et al.
Expert Review of Pharmacoeconomics & Outcomes Research
|
September 30, 2016
Cost-utility analysis of vortioxetine versus agomelatine, bupropion SR, sertraline and venlafaxine XR after treatment switch in major depressive disorder in Finland
Erkki Soini, Taru Hallinen, Mélanie Brignone, et al.
JHLT Open
|
March 27, 2025
Pulmonary hypertension in Finland 2008-2020: A descriptive real-world cohort study (FINPAH)
Markku Pentikäinen, Piia Simonen, Helena Tuunanen, et al.
Pulmonary Circulation
|
February 5, 2025
Treatment pathways in Finnish patients with pulmonary arterial hypertension (PAH) or chronic thromboembolic pulmonary hypertension (CTEPH)
Markku Pentikäinen, Piia Simonen, Pauliina Leskelä, et al.
Scandinavian Journal of Gastroenterology
|
April 6, 2021
A nationwide real-world study on dynamic ustekinumab dosing and concomitant medication use among Crohn's disease patients in Finland
Taina Sipponen, Clas-Göran Af Björkesten, Taru Hallinen, et al.
Scandinavian Journal of Gastroenterology
|
June 12, 2019
Ustekinumab for Crohn's disease: a nationwide real-life cohort study from Finland (FINUSTE)
Anja Eberl, Taru Hallinen, Clas-Göran Af Björkesten, et al.
European Journal of Gastroenterology & Hepatology
|
February 19, 2025
Ustekinumab for ulcerative colitis: a nationwide real-life observational cohort study
Pauliina Molander, Clas-Göran Af Björkesten, Hans Henricson, et al.
Acta Dermato-Venereologica
|
December 14, 2021
Guselkumab Treatment Outcomes and Persistence in a Nationwide Real-world Cohort of Patients with Plaque Psoriasis
Tarja Mälkönen, Pauliina Nuutinen, Taru Hallinen, et al.
European Journal of Gastroenterology & Hepatology
|
September 2, 2020
Objectively assessed disease activity and drug persistence during ustekinumab treatment in a nationwide real-world Crohn's disease cohort
Clas-Göran Af Björkesten, Tuire Ilus, Taru Hallinen, et al.
Page
of 3